Managed Healthcare's Impressive Surge: A Deep Dive into Market Movements and Notable Tickers ๐๐ Theme Description
Managed healthcare firms, including giants like $HUM, $UNH, and $ELV, are in the limelight, registering a +2.29% gain in just a week! Hereโs an analysis of whatโs propelling these stocks.
๐ฅ๐ Uncover Opportunities in Managed Healthcare with AI! ๐ผ๐
The world of managed healthcare offers intriguing prospects, and our AI-powered trading tools are your companions for success in this sector.
๐ "Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)" equips you with the skills to navigate markets trending down, potentially unlocking gains even in challenging conditions.
๐ If you're looking to capitalize on upward trends, "Swing Trader for Beginners: Trading in Markets Trending Up (TA&FA)" is designed to identify these opportunities, empowering you to make informed trading decisions.
With AI precision by your side, you can confidently explore the managed healthcare sector, identify trends, and make strategic moves. Stay ahead of the curve, manage risk, and potentially enhance your returns. Your journey to trading success starts here! ๐๐
Discover the future of trading with AI expertise! ๐ฐ๐ค
ย
Tickers of this Group:
๐ผ Industry Overview
Managed healthcare encompasses giants like Humana Inc., Unitedhealth Group Inc., and Molina Healthcare Inc., which specialize in health insurance and related services. Their chief aim? Cutting healthcare costs for consumers. With a solid growth trajectory, these stocks are setting the stage for future advancements.
๐ฐ Market Cap
Diving into the financials, the average market cap for our theme is a whopping 111.1B. Leading the pack, $UNH boasts a 468.8B valuation, with $BIOS trailing at a still respectable 209.4M.
๐ High and Low Price Notable News
In recent times, the average weekly growth rate is 2.29%. Specifically, $HUM shines with a 4.95% spike, while $BIOS lags behind, dropping by 0.28%. Noteworthy shifts include $CI, which declined -6.36% and $CNC, dipping by -5.56%.
๐ Volume Insights
Volume patterns reveal a -21.38% weekly average, a -42.95% monthly dip but a quarterly upswing of 97.81%. Stocks making waves? $HUM with a daily growth of 150% and Molina Healthcare, with a 355% spike!
๐ข Fundamental Analysis Ratings
A quick snapshot:
๐ Ticker Deep Dive
$CI: A bullish sign emerges as the 10-day MA goes beyond the 50-day average. Over the next month, there's an 86% chance this uptrend will continue.
$HUM: Yet another strong player, Humana's price surpassed its 50-day MA on September 05, 2023. History suggests a 73% probability of this uptrend lasting.
$UNH: Unitedhealth Group witnesses a crossover - its 50-day MA surpasses the 200-day MA. This long-term bullish indicator shows a trend shift upwards.
$ELV: On August 31, 2023, ELV broke its lower Bollinger Band, hinting at a potential rise. Historically, in 73% of similar scenarios, prices ascended the following month.
โจ The managed healthcare sector, with its positive outlook and strong fundamentals, is carving out a space in the limelight. Whether you're observing $HUM's uptrend or $UNH's massive market cap, the sector is ripe with opportunities for discerning traders. Keep a close watch! ๐๐ฅ
ย
CI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 46 cases where CI's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CI advanced for three days, in of 351 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on October 18, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on CI as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for CI turned negative on October 18, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .
CI moved below its 50-day moving average on October 18, 2024 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CI crossed bearishly below the 50-day moving average on October 04, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for CI entered a downward trend on October 25, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.234) is normal, around the industry mean (3.063). P/E Ratio (20.936) is within average values for comparable stocks, (17.509). Projected Growth (PEG Ratio) (0.928) is also within normal values, averaging (1.089). Dividend Yield (0.014) settles around the average of (0.020) among similar stocks. P/S Ratio (0.554) is also within normal values, averaging (0.684).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CIโs price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of health insurance services
Industry ManagedHealthCare